Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Amicus Therapeutics (FOLD) Receivables - Other (2018 - 2019)

Amicus Therapeutics' Receivables - Other history spans 2 years, with the latest figure at $9.0 million for Q1 2019.

  • For the quarter ending Q1 2019, Receivables - Other changed N/A year-over-year to $9.0 million, compared with a TTM value of $9.0 million through Mar 2019, changed N/A, and an annual FY2018 reading of $9.0 million, changed N/A over the prior year.
  • Receivables - Other for Q1 2019 was $9.0 million at Amicus Therapeutics, roughly flat from $9.0 million in the prior quarter.
  • The five-year high for Receivables - Other was $9.0 million in Q4 2018, with the low at $9.0 million in Q4 2018.